CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms

CompletedOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Brain Aneurysm
Interventions
DEVICE

WEB Aneurysm Embolization System

Subjects aged ≥ 18 years, but ≤ 80 years requiring treatment for single ruptured or unruptured intracranial aneurysms.

Trial Locations (4)

1145

National Institute of Clinical Neurosciences, Budapest

31059

Hôpital Purpan, Toulouse

44892

Universitätsklinikum Knappschaftskrankenhaus, Bochum

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03844334 - CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms | Biotech Hunter | Biotech Hunter